The identification and characterization of host-specific probiotic strains represent a critical pathway in the development of Next-Generation Probiotics (NGPs) and Live Biotherapeutic Products (LBPs) for animal and human applications. This resource highlights a recent study titled "Integrative genomic and functional characterization of a feline milk–derived Lactiplantibacillus plantarum MNN reveals host-specific adaptation and ecological safety", analyzing its empirical workflow from genomic sequencing to safety validation. Creative Biolabs provides a comprehensive suite of CRO services and commercial research products designed to support developers executing similar discovery, safety profile assessment, and scalable manufacturing workflows for novel microbial therapeutics.
Overview: Genomic and Functional Profiling of Lactiplantibacillus plantarum MNN1
The analyzed study evaluates Lactiplantibacillus plantarum strain MNN, isolated from feline milk, to determine its genetic adaptations, functional performance, and safety metrics for potential application in companion animal health. The research methodology utilized an integrative workflow combining high-throughput sequencing with comprehensive in vitro phenotypic assays.
Experimental Methodology & Key Frameworks
-
Genomic Sequencing & Assembly: Whole-genome sequencing (WGS) was executed utilizing Oxford Nanopore and Illumina platforms to achieve high-depth coverage and complete chromosome assembly. Bioinformatic analysis focused on identifying core and pan-genomes, carbohydrate-active enzymes (CAZymes), and specific gene clusters associated with host colonization.
-
Host Adaptation Characterization: In silico comparative genomics compared the MNN strain against human- and plant-derived L. plantarum strains to map host-specific genetic evolution. In vitro validation models tested survival rates under simulated gastrointestinal transit conditions (pH 2.0-3.0 and 0.3% bile salt concentrations).
-
Functional Profiles: Evaluation parameters included cell surface hydrophobicity, auto-aggregation, co-aggregation capacities against common pathogens, and precise quantification of short-chain fatty acids (SCFAs) via gas chromatography.
-
Ecological Safety Assessment: The genome was systematically screened for known virulence factors, pathogenic islands, and transmissible antibiotic resistance genes (ARGs) using CARD and VFDB databases. Phenotypic antibiotic susceptibility profiles were corroborated using broth microdilution assays in compliance with European Food Safety Authority (EFSA) standards.
Genomic assembly of L. plantarum MNN revealed a single circular chromosome of approximately 3.25 Mb with a G+C content of 44.5%. Comparative pan-genomic modeling indicated a diverse arsenal of CAZymes, specifically glycoside hydrolases (GHs) and carbohydrate esterases (CEs) tailored to metabolize complex milk oligosaccharides, reflecting host-specific evolutionary adaptation. Phenotypic tests demonstrated that strain MNN maintained over 85% viability following a 3-hour exposure to simulated gastric fluid at pH 2.5. Furthermore, cell surface hydrophobicity reached 68.4%, correlating with strong adherence capabilities. Safety screening confirmed the total absence of plasmid-borne or transmissible resistance genes, and all minimum inhibitory concentrations (MICs) for critical antibiotics fell below the established EFSA epidemiological cut-off values, validating its ecological safety profile.
Aligning LBP R&D Requirements with Premium CRO Services
Translating the experimental workflow of the MNN study into a scalable commercial R&D program requires sophisticated technical infrastructure. Creative Biolabs provides end-to-end services that align precisely with the requirements identified in this research.
Microbial Isolation and Taxonomic Identification
Advanced Genomic and Bioinformatics Analysis
-
De Novo Whole Genome Sequencing: Utilizing Illumina and PacBio (Long-read) technologies for complete circular genome assembly.
-
Comparative Genomics & Pan-genome Analysis: Assessing strain uniqueness, phylogenetic clustering, and niche-specific gene enrichment.
-
Safety Assessment (In Silico): Comprehensive screening for Antibiotic Resistance Genes (ARGs), Virulence Factors (VFs), and Mobile Genetic Elements (MGEs) using updated databases (CARD, VFDB).
Functional Testing & Assays
LBP Safety and Toxicology Assessment
Ready-to-Use Products for Strain Validation
To facilitate rapid in-house screening and benchmarking against established control strains, Creative Biolabs maintains an extensive, quality-controlled catalog of biological materials and analytical standards tailored for microbial research. Matching our established commercial product categories, we provide:
-
Probiotics Products: Pre-formulated microbial matrices suitable for baseline comparison or target optimization studies.
-
Genomic DNAs: Extracted, high-molecular-weight genomic DNA from a broad spectrum of characterized probiotics and quality control strains, optimized for immediate use in PCR verification or comparative genomics.
-
Probiotics DNA Standards: Highly precise quantitative DNA targets designed for the calibration and validation of absolute quantification assays, such as strain-specific qPCR.
Creative Biolabs' Advantages in LBP Discovery
Developing novel biotherapeutic products from isolation to commercial scale-up demands a partner equipped with robust infrastructure and regulatory intelligence. Creative Biolabs provides an integrated technological framework to de-risk the development of live biotherapeutic products.
Integrated Multi-Omics Pipeline
Combining high-depth metagenomics, transcriptomics, and metabolomics into a unified bioinformatic workspace, eliminating data silos and enabling rapid identification of the mechanism of action (MoA).
Advanced In Vitro & In Vivo Platforms
From microfluidic gut-on-a-chip models to validated animal models of gastrointestinal dysbiosis, inflammation, and metabolic disorders, we simulate host environments with high fidelity.
Regulatory Compliance Framework
Every discovery, safety validation, and characterization workflow is mapped against prevailing international guidelines, ensuring that raw data packages transition cleanly into investigational new drug (IND) dossiers.
Diversified Horizons for Novel L. plantarum Strains
-
Companion Animal Therapeutics: Formulation of species-specific next-generation supplements targeting feline and canine inflammatory bowel disease (IBD), age-related gut dysbiosis, and immune modulation.
-
Human Live Biotherapeutic Products (LBPs): Development of prescription-grade or over-the-counter formulations targeting human gastrointestinal disorders, metabolic syndrome, and gut-brain axis indications.
-
Functional Food & Agriculture Bio-preservation: Deployment of robust, antimicrobial lactic acid bacteria strains for organic food preservation, livestock feed efficiency enhancements, and protection against zoonotic pathogen colonization.
Accelerate Your Discovery with a Trusted Research Partner
The exhaustive characterization of Lactiplantibacillus plantarum MNN emphasizes that the future of microbial therapeutics lies in robust, data-driven validation of host specificity and genomic safety. Successfully transitioning from a raw biological isolate to a fully characterized commercial ingredient or a therapeutic LBP candidate requires a reliable, advanced infrastructure. Creative Biolabs stands ready as your dedicated preclinical research partner, offering an uncompromised blend of state-of-the-art CRO services and high-quality product lines. By outsourcing your characterization, multi-omics sequencing, safety screening, and animal efficacy models to our validated platforms, your organization secures robust, regulatory-compliant data packages while significantly reducing internal R&D overhead. We invite principal investigators, development directors, and procurement specialists to initiate contact with our technical support team today.
[Request a Comprehensive Project Quote] or submit an explicit technical inquiry to schedule a detailed consultation with a senior scientist, and discover how our platform can accelerate your next microbial characterization project.
Frequently Asked Questions (FAQs)
Why is host-specific adaptation important for probiotic selection?
As demonstrated in the MNN study, host-adapted strains possess specific genetic clusters (e.g., for metabolizing host-specific sugars) that allow them to survive and colonize more effectively than "universal" strains.
Can you perform comparative genomics against my proprietary strain library?
Absolutely. Our bioinformatics team can perform private pan-genome analyses, comparing your new isolates against both public databases and your internal collections to establish novelty.
How does Creative Biolabs guarantee compliance with EFSA guidelines for antibiotic resistance screening?
We utilize standardized broth microdilution assays to determine the Minimum Inhibitory Concentrations (MICs) for a defined panel of antimicrobials. These phenotypic values are then directly cross-referenced with the latest EFSA cut-off thresholds, backed by whole-genome alignment against updated CARD and ResFinder databases.
Reference
-
Gong, Xinyu et al. "Integrative genomic and functional characterization of a feline milk-derived Lactiplantibacillus plantarum MNN reveals host-specific adaptation and ecological safety." Frontiers in microbiology 17 1742444. 21 Jan. 2026, doi:10.3389/fmicb.2026.1742444. Distributed under Open Access license CC BY 4.0, without modification.
